Synonym: G-CSF
Species: Human
Protein Accession: P09919
Purity: Greater than 95%
Endotoxin Level: Less than 0.1 ng/μg
Biological Activity: The ED50 of Y06201 is typically 0.2-1.0 ng/mL
Expression System: E. coli
Fusion Tag: None
Predicted Molecular Mass: Approximately 19.3 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS
Reconstitution: Reconstitute with sterile water at 0.1 mg/mL
Storage & Stability: Store at -20°C upon receipt, stable for up to 12 months at
-20°C
FAQ
What is Y06201 Recombinant Human G-CSF and how is it used in the feed
industry?
Y06201 Recombinant Human Granulocyte Colony-Stimulating Factor (G-CSF)
is a protein engineered through recombinant DNA technology. Traditionally used in
medical fields to stimulate the bone marrow to produce more white blood cells, it's now
being explored in the feed industry to promote animal health and growth. In the context
of animal feed, G-CSF can boost the immune response, thus helping animals better fight
off infections and recover more rapidly from illnesses. This in turn can lead to
improved health and growth efficiency, contributing to increased productivity and
profitability for livestock producers. Its application in feed can be particularly
effective for animals with compromised immunity or in dealing with stressful conditions
that could otherwise hinder their growth and health.
What benefits does Y06201
Recombinant Human G-CSF offer to livestock?
The primary benefit of Y06201 in
livestock is its ability to enhance the immune system. By stimulating the production of
white blood cells, the protein helps animals fight infections more effectively. This
immune boost can result in fewer disease outbreaks, reduced reliance on antibiotics, and
lower mortality rates. Additionally, healthier animals tend to grow faster and more
efficiently, which can lead to higher yields and better quality produce. Moreover, using
G-CSF can improve recovery times from illnesses, thus ensuring that livestock remain
productive throughout their growth period. This can also mitigate the impact of common
stressors in farming environments, such as weaning, transportation, and environmental
changes.
Are there any safety concerns associated with the use of Y06201 in
animal feed?
The use of recombinant proteins like Y06201 in animal feed is
generally considered safe, given that they are produced in a controlled environment and
undergo rigorous testing. However, it’s crucial to adhere strictly to dosage guidelines
as determined by veterinary health experts to ensure that the animals receive the
maximum benefit without any adverse effects. Overuse or misuse could potentially lead to
issues such as immune system overstimulation. Regulatory bodies often require thorough
evaluation and approval before such products can be widely used in the feed industry.
Similarly, ongoing monitoring and research are necessary to ensure that there are no
long-term negative impacts on the animals or any residues that could affect the human
food chain.
How is Y06201 administered in the feed industry?
Administering
Y06201 typically involves mixing the recombinant protein into the animal feed at precise
concentrations. This integration ensures the protein is ingested consistently as part of
the animal's regular diet. Alternatively, in some specific applications, the protein
might be delivered through injections, especially in situations requiring rapid immune
response activation. The method of integration will depend on several factors, including
the type of livestock, their growth phases, and specific health conditions being
addressed. Veterinary oversight is necessary to tailor the administration protocol to
the specific needs of the livestock, ensuring optimal efficacy and safety.
What
are the economic implications of using Y06201 in livestock
management?
Incorporating Y06201 into livestock management can have significant
economic benefits. By improving overall animal health and resilience, producers can
reduce losses attributable to diseases and infections. Healthier animals mean higher
productivity, whether it's in the form of faster growth, improved feed-to-growth
conversion rates, or higher-quality produce such as milk, meat, or eggs. Additionally, a
reduced need for antibiotics and other medications not only cuts down costs but also
aligns with the increasing consumer demand for antibiotic-free animal products. While
there is an initial investment associated with purchasing the recombinant protein, the
return on investment can be substantial, translating into more robust and efficient
livestock production systems.